𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Infliximab therapy for Crohn's disease: The Crohn's and colitis center of new jersey experience

✍ Scribed by Botros, Nashed; Griffel, Louis H.; Kosa, Emily M.; Prasad, Saket; Das, Kiron M.

Book ID
123266042
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
196 KB
Volume
118
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Durability of infliximab in Crohn's dise
Durability of infliximab in Crohn's disease: A single-center experience
✍ Jason E. Gonzaga; Ashwin N. Ananthakrishnan; Mazen Issa; Dawn B. Beaulieu; Sue S πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 111 KB πŸ‘ 2 views

Background: Infliximab is effective maintenance for moderate to severe Crohn's disease (CD); however, problems with immunogenicity and decreased efficacy often complicate long-term use. Durability of infliximab maintenance therapy over multiple years has not been defined. ## Methods: This was a r

Safety of infliximab in Crohn's disease:
Safety of infliximab in Crohn's disease: A large single-center experience
✍ H. Hamzaoglu; J. Cooper; M. Alsahli; K.R. Falchuk; M.A. Peppercorn; R.J. Farrell πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 135 KB πŸ‘ 2 views

## Background: The aim of this study was to evaluate the shortand long-term safety experience of infliximab treatment in patients with Crohn's disease (CD) in clinical practice. ## Methods: The medical records of 297 consecutive patients with CD treated with infliximab at the Beth Israel Deacon